The loss of BST-2 dimerization-mediated cell to cell/ECM interaction inhibits cancer cell clustering, induces anoikis in breast cancer cells through BST-2/GRB2/ERK/BIM/Cas3 pathway, and inhibits tumor growth and metastasis6. This evidence concerns the gene BST2 and breast carcinoma.